Skip to content

Regenerated Oxidized Cellulose Reinforcement of Low Rectal Anastomosis

Regenerated Oxidized Cellulose Reinforcement of Low Rectal Anastomosis in adults with mid and low rectal cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12609000633280
Enrollment
100
Registered
2009-07-29
Start date
2003-06-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Incidence of leak from low rectal anastomosis is high and diversion is usually needed. Reinforcement of anastomsis might help to decrease leak. Purpose of this work is to study the effect of reinforcing stapled low rectal anastomosis with regenerated oxidized cellulose on the incidence of anastomotic leak.

Interventions

patients had stapled straight low colorectal or colo-anal anastomosis for low rectal cancer without proximal diversion. Patients were prospectively randomized to either regenerated oxidized cellulose reinforcement (OCR) or no reinforcement (NR). Data collected included: age, sex, hemoglobin %, albumin level, histopathologic type of the tumor. Reinforcement was done by integration of the regenerated oxidized cellulose (ROC) in the staple line of the anastomosis. The regenerated oxidized cellulos

patients had stapled straight low colorectal or colo-anal anastomosis for low rectal cancer without proximal diversion. Patients were prospectively randomized to either regenerated oxidized cellulose reinforcement (OCR) or no reinforcement (NR). Data collected included: age, sex, hemoglobin %, albumin level, histopathologic type of the tumor. Reinforcement was done by integration of the regenerated oxidized cellulose (ROC) in the staple line of the anastomosis. The regenerated oxidized cellulose is incorporated in the staple anastomotic line. procedure usually takes 30 mins

Sponsors

Alexandria University hospitals
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

Adults with mid and low rectal cancer

Exclusion criteria

refusal of randomization

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026